Cerebral and Cardiac Blood Flow During Exercise in Patients With COPD (REFLEX-COPD)
Cardiac Output and Brain Perfusion and Architecture During Exercise in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Healthy, Age Matched Volunteers
Heart disease and conditions related to the blood vessels are responsible for a large proportion (over a quarter) of the deaths in people with chronic obstructive pulmonary disease (COPD). The changes can also affect the smaller smaller blood vessels within the body, in particular the brain and the kidneys. This might be related to how the heart pumps and if it is under any pressure. Investigations performed at the University in healthy older volunteers demonstrated how the blood flows in the brain and heart during exercise. Exercise gently puts the whole body under some pressure and therefore exposes any weaker areas.
In this study the investigators are hoping to find out what happens to the blood flow in the brain and in the heart in patients who have COPD when they exercise and in the resting state. This will be compared to people of a similar age with a similar smoking history but without COPD. This will be examined using state of the art magnetic resonance imaging (MRI) and will allow us to assess whether changes in structure and function are related to this altered blood flow.
Our hypothesis is that COPD will cause a larger change in blood flow during exercise compared to the healthy volunteers and that reduced cardiorespiratory fitness will be associated with increased age related structural within the brain.
研究概览
详细说明
The aim is to recruit 20 participants with COPD, who will be compared to 10 age and gender matched controls who also have a smoking history. The investigators aim for this number to complete the components of the study and therefore may have to over-recruit if some people drop out or are not eligible. The study elements are feasible, as the work extends a previous research study in healthy volunteers.
This research trial will consist of a medical screening visit and three investigation study visits spaced ideally one week apart. The investigation visits will begin within 6 (ideally within 4) weeks of the medical screening visit. The total duration of the study and screening visits should be 12 weeks maximum for each participant.
Screening visit:
If the participant expresses an interest in the clinical trial and wants to take part they will be invited (at a convenient time for them) to attend a medical screening visit located at the Nottingham City hospital. Here the investigator will discuss the research trial and answer any questions or concerns they might have regarding the research trial. The participant, if willing, will then be required to sign a consent form so that the screening procedures can begin, which include:
- Blood sample: Approximately a 20ml sample (4 teaspoons) taken from their arm, for further investigation including full blood count (FBC), brain natriuretic peptide (BNP) and kidney function.
- Questionnaires: 5 different questionnaires that ask about symptoms and how they affect daily life, a physical activity questionnaire, quality of life questionnaire and a MRI safety questionnaire.
- Spirometry: A simple blowing test to assess the participants' breathing which is performed three times.
- 12 lead ECG.
- a hand grip dynamometer to assess muscle strength
- timed up and go test: a test used to measure gait speed, where participants are asked to get up from a chair and walking to 3 meters and back, whilst being timed.
- to wear a step counter (Sensewear armband) for a week during waking hours to record steps.
Provided the ECG, step count (<10,000 steps) and other screening elements are ok, the participant will proceed to Study visit 1.
Strength and exercise test protocol:
The participant will be required to abstain from strenuous exercise for the 48 hours prior to the visit and also from alcohol and caffeine for 24 hours prior. Upon arrival they will perform a knee extension exercise so we can establish the muscle strength in the legs, specifically 3 maximal knee extensions with a 30 second rest in between. We will also measure fatigue by dong 20 extensions after a short break.
After a break they will then undergo an exercise test using an MRI compatible stepper device (Ergospect Cardiostepper) whilst in a supine position. This has been adapted to be similar to how they will exercise in the MRI scanner. Volunteers will start off stepping at a frequency of 65-70 steps a minute at the minimum workload and every 3 minutes get gradually a little harder until exhaustion is reached. Heart rate at rest and in response to exercise will be measured using a heart monitor. Participants will be given the option to have their expired gases also measured during exercise using a face mask, though this is not necessary if not tolerated. In the final minute of each workload we will take a finger prick test to measure the gases in the patients blood. A 3 lead ECG and oxygen saturation probe will be attached during exercise as safety measures and the protocol will be halted if oxygen saturation falls below 80% or if any relevant rhythm abnormalities are seen on the ECG trace.
The second study visit will be used to confirm the exercise and strength parameters measured in the first study visit.
MRI protocol:
A series of scans of the brain and heart will be taken at rest and then whilst stepping on the stepper machine within the MRI. The exercise will be at a steady state low level intensity determined by calculating the workload at which a fraction of maximum heart rate was achieved during first 2 study visits.
The MRI scan itself will take about ¾ hour but upto 2 hours is allowed for preparation and introducing the scan to the participant. The scanner is quite noisy and so the participant will wear ear defenders during the scan. Because the scanner is built around a large magnet, the participant will be instructed to remove all metal from their body, including jewellery. There is no radiation involved.
研究类型
注册 (预期的)
联系人和位置
学习地点
-
-
Nottinghamshire
-
Nottingham、Nottinghamshire、英国、NG5 1PB
- 招聘中
- NIHR Nottingham BRC Respiratory Theme, University of Nottingham and NUH Trust
-
接触:
- Ayushman Gupta
- 电话号码:01158231702
- 邮箱:mszag4@exmail.nottingham.ac.uk
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
描述
Inclusion Criteria:
- Patients aged 65-75 years old,
- >10 pack years smoking,
- FEV1/FVC <0.7 and FEV1<60% predicted (for COPD participants only)
- Sedentary lifestyle (<10,000 steps per day)
- Able to give informed consent
- Able to read, understand and communicate coherently in English
Exclusion Criteria:
- Doctor diagnosis of ischaemic heart disease or heart failure
- Doctor diagnosis of dementia or Alzheimers disease
- History of previous cerebrovascular disease (stroke or TIA) or malignancy
- Pregnancy or childbearing in the last 6 months
- Maintenance oral corticosteroids in the past 6 months
- Requirement for oral corticosteroids or antibiotics in the past 6 weeks
- Active arthritis or other muscular condition limiting exercise
- Surgical intervention in the last 12 weeks
- Long term oxygen therapy requirement
- Other formal current respiratory diagnosis
- Thyroid disease
- Diabetes Mellitus
- Neurological or cognitive impairment
- Significant physical disability
- Any other conditions in addition to the above that the investigators consider may affect study measurements or safety
- Inability to understand verbal and/or written explanation of the study requirements
学习计划
研究是如何设计的?
设计细节
- 观测模型:病例对照
- 时间观点:横截面
队列和干预
团体/队列 |
|---|
|
Case
Participants with a pack year history of more than 10 pack years, diagnosed with COPD who have FEV1/FVC ratio of less than 0.7 AND FEV1 predicted value less than or equal to 60%.
|
|
Control
Participants without a diagnosis of COPD who have a smoking history of more than 10 pack years
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Resting white and grey matter structural integrity
大体时间:up to 12 weeks
|
Grey and white matter volume (mm3) using the MRI MPRAGE sequences will be measured at rest
|
up to 12 weeks
|
|
Cardiac structural integrity
大体时间:up to 12 weeks
|
Cardiac output (L/min) will be measured using the MRI sequence (Short axis Cine) at rest.
|
up to 12 weeks
|
|
Cardiac structural integrity
大体时间:up to 12 weeks
|
Cardiac fibrosis (%) will be measured using the MRI MOLLI T1 sequence at rest.
|
up to 12 weeks
|
|
Cardiac structural integrity
大体时间:up to 12 weeks
|
Myocardial strain (%) will be measured using the MRI cardiac tagging sequence at rest.
|
up to 12 weeks
|
|
Whole body fat and muscle quantification
大体时间:up to 12 weeks
|
Whole body fat and muscle quantification (%) will be measured using the MRI whole body mdixon sequence at rest.
|
up to 12 weeks
|
|
Aortic flow
大体时间:up to 12 weeks
|
Aortic flow (ml/min) will be measured during rest, low level steady-state exercise and following cessation of exercise and compared between COPD and age and gender matched controls
|
up to 12 weeks
|
|
Cerebral blood flow
大体时间:up to 12 weeks
|
Cerebral blood flow (ml/min) will be measured during rest, low level steady-state exercise and following cessation of exercise and compared between COPD and age and gender matched controls
|
up to 12 weeks
|
|
Cerebral perfusion
大体时间:up to 12 weeks
|
Cerebral artery perfusion (ml/100g/min) will be measured during rest, low level steady-state exercise and following cessation of exercise and compared between COPD and age and gender matched controls
|
up to 12 weeks
|
|
Oxygen extraction fraction
大体时间:up to 12 weeks
|
Oxygen extraction fraction (%) will be derived from the difference between arterial and venous cerebral oxygenation measured via TRUST MRI scan sequence during rest, low level steady-state exercise and following cessation of exercise and compared between COPD and age and gender matched controls
|
up to 12 weeks
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Muscle isometric strength (MVC)
大体时间:up to 6 weeks
|
Isometric muscle torque of the quadriceps (Nm) assessed using the cybex dynamometer
|
up to 6 weeks
|
|
Muscle isokinetic fatigue
大体时间:up to 6 weeks
|
Fatiguability test of the quadriceps (Nm) assessed using the cybex dynamometer
|
up to 6 weeks
|
|
Quality of life (SGRQ)
大体时间:1 week
|
Assessed using the St Georges Respiratory Questionnaire.
min value: 0, max value: 84, higher score means worse outcome
|
1 week
|
|
Physical activity level (IPAQ Physical activity questionnaire)
大体时间:1 week
|
Assessed using the International Physical activity questionnaire.
min value: 0, max value: 66000, higher score means better outcome
|
1 week
|
|
Montreal Cognitive Assessment (MoCA) cognition level
大体时间:1 week
|
Assessed using the Montreal cognitive assessment questionnaire.
min value: 0, max value: 30, higher score means better outcome
|
1 week
|
|
Hospital anxiety and depression scale (HADS)
大体时间:1 week
|
min value: 0, max value: 21, higher score means worse outcome
|
1 week
|
|
Hand grip strength
大体时间:1 week
|
Composite of hand grip strength (Kg), measured by a hand held dynamometer,
|
1 week
|
|
Timed up and go test
大体时间:1 week
|
Timed up and go test (seconds) will be measured to assess degree of frailty.
|
1 week
|
|
Serum markers of inflammation for research purposes (likely to include IL-1, IL-6, and TNFα)
大体时间:1 week
|
Blood test
|
1 week
|
|
Heart rate response to exercise
大体时间:up to 6 weeks
|
Heart rate response (Beats per minute) will be measured at rest and during incremental exercise to assess cardio-respiratory fitness.
|
up to 6 weeks
|
合作者和调查者
调查人员
- 首席研究员:Charlotte Bolton、NIHR Nottingham Biomedical Research Centre Respiratory theme, University of Nottingham
出版物和有用的链接
一般刊物
- Blair SN, Kohl HW 3rd, Paffenbarger RS Jr, Clark DG, Cooper KH, Gibbons LW. Physical fitness and all-cause mortality. A prospective study of healthy men and women. JAMA. 1989 Nov 3;262(17):2395-401. doi: 10.1001/jama.262.17.2395.
- McGarvey LP, John M, Anderson JA, Zvarich M, Wise RA; TORCH Clinical Endpoint Committee. Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax. 2007 May;62(5):411-5. doi: 10.1136/thx.2006.072348. Epub 2007 Feb 20.
- Sabit R, Bolton CE, Edwards PH, Pettit RJ, Evans WD, McEniery CM, Wilkinson IB, Cockcroft JR, Shale DJ. Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007 Jun 15;175(12):1259-65. doi: 10.1164/rccm.200701-067OC. Epub 2007 Mar 15.
- John M, Hussain S, Prayle A, Simms R, Cockcroft JR, Bolton CE. Target renal damage: the microvascular associations of increased aortic stiffness in patients with COPD. Respir Res. 2013 Mar 5;14(1):31. doi: 10.1186/1465-9921-14-31.
- Erickson KI, Leckie RL, Weinstein AM. Physical activity, fitness, and gray matter volume. Neurobiol Aging. 2014 Sep;35 Suppl 2:S20-8. doi: 10.1016/j.neurobiolaging.2014.03.034. Epub 2014 May 14.
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (预期的)
研究完成 (预期的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- 18063
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.